These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37943040)

  • 1. Phage Milagro: a platform for engineering a broad host range virulent phage for
    Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ
    J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040
    [No Abstract]   [Full Text] [Related]  

  • 2. The temperate Burkholderia phage AP3 of the Peduovirinae shows efficient antimicrobial activity against B. cenocepacia of the IIIA lineage.
    Roszniowski B; Latka A; Maciejewska B; Vandenheuvel D; Olszak T; Briers Y; Holt GS; Valvano MA; Lavigne R; Smith DL; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2017 Feb; 101(3):1203-1216. PubMed ID: 27770178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.
    Lynch KH; Dennis JJ
    Can J Microbiol; 2012 Mar; 58(3):221-35. PubMed ID: 22339239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic Interactions among
    Lauman P; Dennis JJ
    Microbiol Spectr; 2023 Jun; 11(3):e0443022. PubMed ID: 37195168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage-antibiotic synergy reduces Burkholderia cenocepacia population.
    Mankovich AG; Maciel K; Kavanaugh M; Kistler E; Muckle E; Weingart CL
    BMC Microbiol; 2023 Jan; 23(1):2. PubMed ID: 36600213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the Diversity of
    Nordstrom HR; Griffith MP; Rangachar Srinivasa V; Wallace NR; Li A; Cooper VS; Shields RK; Van Tyne D
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474392
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of a PRD1-like phage uncovers the carriage of three putative conjugative plasmids in clinical Burkholderia contaminans.
    Stanton CR; Petrovski S; Batinovic S
    Res Microbiol; 2024; 175(5-6):104202. PubMed ID: 38582389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia contaminans Bacteriophage CSP3 Requires O-Antigen Polysaccharides for Infection.
    Stanton CR; Batinovic S; Petrovski S
    Microbiol Spectr; 2023 Jun; 11(3):e0533222. PubMed ID: 37199610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections.
    Semler DD; Lynch KH; Dennis JJ
    Front Cell Infect Microbiol; 2011; 1():27. PubMed ID: 22919592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.
    Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785625
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and Characterization of a Novel Jumbo Phage from Leaf Litter Compost and Its Suppressive Effect on Rice Seedling Rot Diseases.
    Sasaki R; Miyashita S; Ando S; Ito K; Fukuhara T; Takahashi H
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33807245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Phage Therapy: Targeting the
    Lauman P; Dennis JJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage steering of
    Ruest MK; Supina BSI; Dennis JJ
    J Bacteriol; 2023 Oct; 205(10):e0019623. PubMed ID: 37791751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans.
    Haidar G; Chan BK; Cho ST; Hughes Kramer K; Nordstrom HR; Wallace NR; Stellfox ME; Holland M; Kline EG; Kozar JM; Kilaru SD; Pilewski JM; LiPuma JJ; Cooper VS; Shields RK; Van Tyne D
    Transpl Infect Dis; 2023 Apr; 25(2):e14041. PubMed ID: 36864824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.
    Semler DD; Goudie AD; Finlay WH; Dennis JJ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4005-13. PubMed ID: 24798268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
    Kamal F; Dennis JJ
    Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.
    Lourenço M; Osbelt L; Passet V; Gravey F; Megrian D; Strowig T; Rodrigues C; Brisse S
    Microbiol Spectr; 2023 Aug; 11(4):e0481222. PubMed ID: 37338376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R; Jones AM; Horsley A
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009529. PubMed ID: 32239690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM; Lord R
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009529. PubMed ID: 26789750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.